Data on halting the progression of CKD using non-purine selective xanthine oxidase inhibitor to lower uric acid have been insufficient (6, 7), although a number of studies demonstrated that uric acid was associated with the pathogenesis of kidney injury through endothelial dysfunction and inflammation (8, 9). Here, XDH is linked to chronic kidney disease.